KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 11 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,154,000 | +160.1% | 5,000,000 | +150.0% | 0.15% | +163.2% |
| Q4 2021 | $1,597,000 | +6.9% | 2,000,000 | 0.0% | 0.06% | -10.9% |
| Q3 2021 | $1,494,000 | -25.0% | 2,000,000 | 0.0% | 0.06% | -22.0% |
| Q2 2021 | $1,991,000 | -47.3% | 2,000,000 | -33.3% | 0.08% | -43.4% |
| Q4 2020 | $3,781,000 | +4.9% | 3,000,000 | 0.0% | 0.14% | -14.7% |
| Q3 2020 | $3,603,000 | +28.2% | 3,000,000 | +50.0% | 0.17% | +6.9% |
| Q2 2020 | $2,811,000 | -35.2% | 2,000,000 | -33.3% | 0.16% | -53.5% |
| Q1 2020 | $4,337,000 | +0.4% | 3,000,000 | 0.0% | 0.34% | +43.1% |
| Q4 2019 | $4,318,000 | – | 3,000,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 20,000,000 | $25,176,000 | 1.70% |
| DeepCurrents Investment Group LLC | 22,530,000 | $28,226,000 | 0.74% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $24,888,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 35,000,000 | $43,527,000 | 0.26% |
| AQR Arbitrage LLC | 4,100,000 | $5,164,000 | 0.18% |
| CSS LLC/IL | 3,000,000 | $3,781,000 | 0.14% |
| Verition Fund Management LLC | 6,579,000 | $8,286,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 16,500,000 | $20,780,000 | 0.03% |
| Citadel Advisors | 43,300,000 | $54,252,000 | 0.01% |
| CREDIT SUISSE AG/ | 5,017,000 | $6,243,000 | 0.00% |